Kenai Therapeutics

Cambridge, MA · Founded 2022 · Privately Held (backing)

Operator of a biotechnology company intended to cure neurological disease. Kenai Therapeutics is based in Cambridge, MA and was founded in 2022. Its last known valuation is $110 million. It has raised $86.8 million.

Last price · $/share

—

Implied valuation

$110.0M

Total raised

$86.8M

Last round

—

How much has Kenai Therapeutics raised?

$86.8Macross 0 recorded rounds

Free account

More of Kenai Therapeutics with a free account

·Watch Kenai Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Kenai Therapeutics investors

6 investors are on record for Kenai Therapeutics, including Euclidean Capital, Alaska Permanent Fund, California Institute for Regenerative Medicine and Cure Ventures.

For fundraisers

Raising for a company like Kenai Therapeutics?

6 investors have backed Kenai Therapeutics.

See all 6 investors →

Frequently asked about Kenai Therapeutics

How much has Kenai Therapeutics raised?: Kenai Therapeutics has raised $86.8M in total across 0 recorded funding rounds.